{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T17:22:35Z","timestamp":1775841755894,"version":"3.50.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82101878"],"award-info":[{"award-number":["82101878"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Northern Jiangsu People's Hospital","award":["SBKY21006"],"award-info":[{"award-number":["SBKY21006"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1007\/s10067-024-07265-z","type":"journal-article","created":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T07:36:16Z","timestamp":1734334576000},"page":"341-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low serum S100A6 levels are associated RP-ILD risk in anti-MDA5-positive dermatomyositis"],"prefix":"10.1007","volume":"44","author":[{"given":"Wei","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yumeng","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanxiao","family":"You","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jieting","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Defang","family":"Meng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuexiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xindi","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenfeng","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6241-9868","authenticated-orcid":false,"given":"Hua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,16]]},"reference":[{"issue":"1","key":"7265_CR1","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1038\/s41572-021-00321-x","volume":"7","author":"IE Lundberg","year":"2021","unstructured":"Lundberg IE et al (2021) Idiopathic inflammatory myopathies. Nat Rev Dis Primers 7(1):86","journal-title":"Nat Rev Dis Primers"},{"issue":"5","key":"7265_CR2","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/art.21023","volume":"52","author":"S Sato","year":"2005","unstructured":"Sato S et al (2005) Autoantibodies to a 140-kd polypeptide, CADM-140, in Japanese patients with clinically amyopathic dermatomyositis. Arthritis Rheum 52(5):1571\u20131576","journal-title":"Arthritis Rheum"},{"issue":"3","key":"7265_CR3","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1093\/rheumatology\/kep375","volume":"49","author":"R Nakashima","year":"2010","unstructured":"Nakashima R et al (2010) The RIG-I-like receptor IFIH1\/MDA5 is a dermatomyositis-specific autoantigen identified by the anti-CADM-140 antibody. Rheumatology (Oxford) 49(3):433\u2013440","journal-title":"Rheumatology (Oxford)"},{"issue":"2","key":"7265_CR4","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1073\/pnas.022637199","volume":"99","author":"DC Kang","year":"2002","unstructured":"Kang DC et al (2002) mda-5: An interferon-inducible putative RNA helicase with double-stranded RNA-dependent ATPase activity and melanoma growth-suppressive properties. Proc Natl Acad Sci U S A 99(2):637\u2013642","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"7265_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1038\/s41392-020-00438-7","volume":"5","author":"Y Zheng","year":"2020","unstructured":"Zheng Y et al (2020) Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) membrane (M) protein inhibits type I and III interferon production by targeting RIG-I\/MDA-5 signaling. Signal Transduct Target Ther 5(1):299","journal-title":"Signal Transduct Target Ther"},{"issue":"9","key":"7265_CR6","doi-asserted-by":"publisher","first-page":"e1003610","DOI":"10.1371\/journal.ppat.1003610","volume":"9","author":"A Nikonov","year":"2013","unstructured":"Nikonov A et al (2013) RIG-I and MDA-5 detection of viral RNA-dependent RNA polymerase activity restricts positive-strand RNA virus replication. PLoS Pathog 9(9):e1003610","journal-title":"PLoS Pathog"},{"issue":"6","key":"7265_CR7","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1097\/BOR.0000000000000908","volume":"34","author":"E Fuzzi","year":"2022","unstructured":"Fuzzi E et al (2022) Anti-MDA5 dermatomyositis: an update from bench to bedside. Curr Opin Rheumatol 34(6):365\u2013373","journal-title":"Curr Opin Rheumatol"},{"issue":"1","key":"7265_CR8","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1212\/WNL.0000000000009727","volume":"95","author":"Y Allenbach","year":"2020","unstructured":"Allenbach Y et al (2020) Different phenotypes in dermatomyositis associated with anti-MDA5 antibody: Study of 121 cases. Neurology 95(1):e70\u2013e78","journal-title":"Neurology"},{"issue":"2","key":"7265_CR9","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/s12016-020-08822-5","volume":"60","author":"W Wu","year":"2021","unstructured":"Wu W et al (2021) Interstitial Lung Disease in Anti-MDA5 Positive Dermatomyositis. Clin Rev Allergy Immunol 60(2):293\u2013304","journal-title":"Clin Rev Allergy Immunol"},{"issue":"15","key":"7265_CR10","doi-asserted-by":"publisher","first-page":"2749","DOI":"10.1007\/s00018-017-2526-9","volume":"74","author":"R Donato","year":"2017","unstructured":"Donato R, Sorci G, Giambanco I (2017) S100A6 protein: functional roles. Cell Mol Life Sci 74(15):2749\u20132760","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"7265_CR11","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.3390\/ijms24021341","volume":"24","author":"W Lesniak","year":"2023","unstructured":"Lesniak W, Filipek A (2023) S100A6 Protein-Expression and Function in Norm and Pathology. Int J Mol Sci 24(2):1341","journal-title":"Int J Mol Sci"},{"issue":"2","key":"7265_CR12","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/nrc3893","volume":"15","author":"AR Bresnick","year":"2015","unstructured":"Bresnick AR, Weber DJ, Zimmer DB (2015) S100 proteins in cancer. Nat Rev Cancer 15(2):96\u2013109","journal-title":"Nat Rev Cancer"},{"issue":"12","key":"7265_CR13","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.2174\/13816128113199990444","volume":"20","author":"JT Tsoporis","year":"2014","unstructured":"Tsoporis JT et al (2014) Conditional cardiac overexpression of S100A6 attenuates myocyte hypertrophy and apoptosis following myocardial infarction. Curr Pharm Des 20(12):1941\u20131949","journal-title":"Curr Pharm Des"},{"key":"7265_CR14","doi-asserted-by":"crossref","unstructured":"Mofid A, et al (2017) Cardiac overexpression of S100A6 attenuates cardiomyocyte apoptosis and reduces infarct size after myocardial ischemia-reperfusion. J Am Heart Assoc 6(2)","DOI":"10.1161\/JAHA.116.004738"},{"key":"7265_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2018.05.030","volume":"833","author":"P Xia","year":"2018","unstructured":"Xia P et al (2018) Therapeutic effects of recombinant human S100A6 and soluble receptor for advanced glycation end products(sRAGE) on CCl(4)-induced liver fibrosis in mice. Eur J Pharmacol 833:86\u201393","journal-title":"Eur J Pharmacol"},{"issue":"4","key":"7265_CR16","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1038\/sj.bjc.6602034","volume":"91","author":"I Rehman","year":"2004","unstructured":"Rehman I et al (2004) S100A6 (Calcyclin) is a prostate basal cell marker absent in prostate cancer and its precursors. Br J Cancer 91(4):739\u2013744","journal-title":"Br J Cancer"},{"issue":"3","key":"7265_CR17","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s00109-013-1104-3","volume":"92","author":"Z Li","year":"2014","unstructured":"Li Z et al (2014) Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma. J Mol Med (Berl) 92(3):291\u2013303","journal-title":"J Mol Med (Berl)"},{"issue":"3","key":"7265_CR18","doi-asserted-by":"publisher","first-page":"781","DOI":"10.3892\/ijo.2013.2231","volume":"44","author":"L Duan","year":"2014","unstructured":"Duan L et al (2014) S100A6 stimulates proliferation and migration of colorectal carcinoma cells through activation of the MAPK pathways. Int J Oncol 44(3):781\u2013790","journal-title":"Int J Oncol"},{"issue":"3","key":"7265_CR19","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.lungcan.2008.06.003","volume":"63","author":"L De Petris","year":"2009","unstructured":"De Petris L et al (2009) Tumor expression of S100A6 correlates with survival of patients with stage I non-small-cell lung cancer. Lung Cancer 63(3):410\u2013417","journal-title":"Lung Cancer"},{"issue":"4","key":"7265_CR20","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/S1386-6346(02)00008-6","volume":"23","author":"J Kim","year":"2002","unstructured":"Kim J et al (2002) S100A6 protein as a marker for differential diagnosis of cholangiocarcinoma from hepatocellular carcinoma. Hepatol Res 23(4):274","journal-title":"Hepatol Res"},{"issue":"6","key":"7265_CR21","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1016\/j.placenta.2014.03.017","volume":"35","author":"E Jurewicz","year":"2014","unstructured":"Jurewicz E et al (2014) S100A6 and its extracellular targets in Wharton\u2019s jelly of healthy and preeclamptic patients. Placenta 35(6):386\u2013391","journal-title":"Placenta"},{"issue":"1","key":"7265_CR22","first-page":"165","volume":"58","author":"C Landi","year":"2019","unstructured":"Landi C et al (2019) Bronchoalveolar lavage proteomic analysis in pulmonary fibrosis associated with systemic sclerosis: S100A6 and 14-3-3epsilon as potential biomarkers. Rheumatology (Oxford) 58(1):165\u2013178","journal-title":"Rheumatology (Oxford)"},{"issue":"4","key":"7265_CR23","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/art.42308","volume":"75","author":"L Xu","year":"2023","unstructured":"Xu L et al (2023) Identification of Three Different Phenotypes in Anti-Melanoma Differentiation-Associated Gene 5 Antibody-Positive Dermatomyositis Patients: Implications for Prediction of Rapidly Progressive Interstitial Lung Disease. Arthritis Rheumatol 75(4):609\u2013619","journal-title":"Arthritis Rheumatol"},{"issue":"7","key":"7265_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1056\/NEJM197502132920706","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292(7):344\u2013347","journal-title":"N Engl J Med"},{"issue":"8","key":"7265_CR25","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1056\/NEJM197502202920807","volume":"292","author":"A Bohan","year":"1975","unstructured":"Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292(8):403\u2013407","journal-title":"N Engl J Med"},{"key":"7265_CR26","doi-asserted-by":"publisher","first-page":"151959","DOI":"10.1016\/j.semarthrit.2022.151959","volume":"53","author":"M McPherson","year":"2022","unstructured":"McPherson M et al (2022) Management of MDA-5 antibody positive clinically amyopathic dermatomyositis associated interstitial lung disease: A systematic review. Semin Arthritis Rheum 53:151959","journal-title":"Semin Arthritis Rheum"},{"issue":"24","key":"7265_CR27","doi-asserted-by":"publisher","first-page":"9473","DOI":"10.3390\/ijms21249473","volume":"21","author":"AS Kazakov","year":"2020","unstructured":"Kazakov AS et al (2020) Interferon beta activity is modulated via binding of specific S100 proteins. Int J Mol Sci 21(24):9473","journal-title":"Int J Mol Sci"},{"issue":"4","key":"7265_CR28","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.3390\/ijms23041997","volume":"23","author":"AS Kazakov","year":"2022","unstructured":"Kazakov AS et al (2022) Interferon-beta activity is affected by S100B protein. Int J Mol Sci 23(4):1997","journal-title":"Int J Mol Sci"},{"issue":"10","key":"7265_CR29","doi-asserted-by":"publisher","first-page":"17561","DOI":"10.1002\/jcp.28379","volume":"234","author":"A Graczyk-Jarzynka","year":"2019","unstructured":"Graczyk-Jarzynka A et al (2019) S100A6 activates EGFR and its downstream signaling in HaCaT keratinocytes. J Cell Physiol 234(10):17561\u201317569","journal-title":"J Cell Physiol"},{"issue":"3","key":"7265_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.3390\/genes11030306","volume":"11","author":"J Dou","year":"2020","unstructured":"Dou J et al (2020) Heat stress impairs the physiological responses and regulates genes coding for extracellular exosomal proteins in rat. Genes (Basel) 11(3):306","journal-title":"Genes (Basel)"},{"issue":"11","key":"7265_CR31","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.15252\/embr.201540337","volume":"16","author":"S Chattopadhyay","year":"2015","unstructured":"Chattopadhyay S et al (2015) EGFR kinase activity is required for TLR4 signaling and the septic shock response. EMBO Rep 16(11):1535\u20131547","journal-title":"EMBO Rep"},{"issue":"1","key":"7265_CR32","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1465-9921-12-97","volume":"12","author":"S Kawase","year":"2011","unstructured":"Kawase S et al (2011) Change in serum KL-6 level from baseline is useful for predicting life-threatening EGFR-TKIs induced interstitial lung disease. Respir Res 12(1):97","journal-title":"Respir Res"},{"issue":"2","key":"7265_CR33","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/j.yexcr.2004.10.018","volume":"303","author":"JN Tsoporis","year":"2005","unstructured":"Tsoporis JN et al (2005) S100A6 is a negative regulator of the induction of cardiac genes by trophic stimuli in cultured rat myocytes. Exp Cell Res 303(2):471\u2013481","journal-title":"Exp Cell Res"},{"issue":"5","key":"7265_CR34","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/jpm11050368","volume":"11","author":"P Balanescu","year":"2021","unstructured":"Balanescu P et al (2021) S100A6, calumenin and cytohesin 2 as biomarkers for cutaneous involvement in systemic sclerosis patients: a case control study. J Pers Med 11(5):368","journal-title":"J Pers Med"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07265-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-024-07265-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-024-07265-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T13:40:23Z","timestamp":1736775623000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-024-07265-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,16]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["7265"],"URL":"https:\/\/doi.org\/10.1007\/s10067-024-07265-z","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,16]]},"assertion":[{"value":"18 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"None.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}}]}}